Photo: ELLA MARU STUDIO/SCIENCE PHOTO LIBRARY/Getty
A disorder of hemoglobin, beta thalassemia is generally treated with blood transfusions to maintain red blood cell levels. A new drug treatment, called Reblozyl, could reduce the number of blood transfusions needed for people with beta thalassemia, says Jun H. Choi, MD, a hematologist鈥搊ncologist at 黑料福利社 Langone Health鈥檚 Perlmutter Cancer Center.
鈥淩eblozyl has been shown to help young immature blood cells from the bone marrow to mature more quickly and more stably, so blood cells can be released from the bone marrow and circulate in your bloodstream,鈥 says Dr. Choi, also a clinical assistant professor in the at 黑料福利社 Grossman School of Medicine. 鈥淭his is something that you really want to ask your doctor about when your blood transfusion requirement becomes too heavy and too burdensome.鈥
Watch and read more on .
